Valuation: Cannabis Bioscience International Holdings, Inc.

Market Cap 2.37M 2.12M 1.95M 1.77M 3.3M 225M 3.37M 23.26M 9.34M 118M 8.89M 8.7M 373M P/E 2024
-9.52x
P/E 2025 -11.8x
Enterprise Value 3.37M 3.02M 2.77M 2.51M 4.7M 320M 4.79M 33.09M 13.28M 168M 12.64M 12.37M 531M EV / Sales 2024
28.9x
EV / Sales 2025 25.6x
Free-Float
41.59%
Yield 2024 *
-
Yield 2025 -
07-15 Cannabis Bioscience International Holdings Receives Texas License for Consumable Hemp Products CI
04-16 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 CI
02-19 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025 CI
22/10/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 CI
06/10/25 Cannabis Bioscience International Holdings, Inc Appoints Andy Trivedi to Its Board of Directors CI
22/09/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Full Year Ended May 31, 2025 CI
21/09/25 Cannabis Bioscience International Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
22/04/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025 CI
21/01/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024 CI
06/01/25 Cannabis Bioscience International Holdings Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products CI
26/12/24 Cannabis Bioscience International Holdings, Inc. announced that it has received $0.075 million in funding CI
26/11/24 Cannabis Bioscience International Holdings, Inc. Appoints Charles Tamburello as Directors, Effective December 1, 2024 CI
25/11/24 Cannabis Bioscience International Holdings, Inc. Unveils the Future of Wellness with Revolutionary Anti-Aging Chip CI
1 day+33.33%
3 months+33.33%
6 months-33.33%
Current year-60.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 1.0E-6
0.27
Manager TitleAgeSince
Chief Executive Officer 70 18/12/2019
Treasurer 61 05/05/2024
Corporate Secretary 66 18/12/2019
Director TitleAgeSince
Director/Board Member 70 18/12/2019
Director/Board Member 66 18/12/2019
Director/Board Member 61 05/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
+33.33%0.00%-60.00%-71.43% 2.44M
-0.62%-1.87%+46.31%+56.99% 63.77B
+0.35%+3.20%+14.92%+84.55% 56.37B
+0.53%+1.96%+15.37%+106.81% 54.62B
-2.81%-4.31%+23.50%+50.90% 44.06B
-0.33%-1.93%+20.15%+98.45% 42.11B
+0.55%+2.31%+224.97%+942.56% 41B
+3.27%+47.96%+112.67%+96.48% 34.92B
+1.22%-1.44%+14.89%+47.15% 32.82B
+0.89%+20.55%-42.03%+373.03% 24.7B
Average +3.64%+6.79%+37.07%+178.55% 39.43B
Weighted average by Cap. +0.18%+5.44%+48.50%+186.13%

Financials

2024 2025
Net sales 249K 223K 205K 186K 347K 23.63M 354K 2.44M 981K 12.43M 934K 914K 39.2M 303K 271K 250K 226K 423K 28.77M 431K 2.98M 1.2M 15.13M 1.14M 1.11M 47.73M
Net income -651K -583K -537K -486K -909K -61.85M -926K -6.4M -2.57M -32.53M -2.44M -2.39M -103M -549K -492K -452K -410K -766K -52.11M -780K -5.39M -2.16M -27.41M -2.06M -2.02M -86.45M
Net Debt 939K 841K 774K 701K 1.31M 89.19M 1.34M 9.23M 3.7M 46.92M 3.53M 3.45M 148M 1M 896K 824K 747K 1.4M 94.99M 1.42M 9.83M 3.95M 49.97M 3.75M 3.67M 158M
Projected Income Statement - Annual - Cannabis Bioscience International Holdings, Inc.
Logo Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company provides educational systems focused on medical cannabis in the United States and Latin America, as well as worldwide through online education, services in therapeutic areas of clinical trials. Through its Alpha Research Business, based in Houston, Texas, it offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. It offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients, and others who desire to participate in the cannabis industry.
Employees
2
Date Price Change Volume
30/10/26 US$0.000200 +33.33% 145,000
29/10/26 US$0.000150 0.00% 95,101
28/10/26 US$0.000150 -25.00% 1,240,000
27/10/26 US$0.000200 +48.15% 7,150
26/10/26 US$0.000135 -32.50% 2,002,550
  1. Stock Market
  2. Stocks
  3. CBIH Stock